Amalgamated Bank’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,091
Closed -$26K 2989
2024
Q4
$26K Hold
2,091
﹤0.01% 2027
2024
Q3
$24K Hold
2,091
﹤0.01% 2065
2024
Q2
$15K Hold
2,091
﹤0.01% 2257
2024
Q1
$14K Sell
2,091
-6,694
-76% -$46.1K ﹤0.01% 2304
2023
Q4
$57K Sell
8,785
-19,623
-69% -$126K ﹤0.01% 2191
2023
Q3
$268K Hold
28,408
﹤0.01% 1674
2023
Q2
$397K Buy
28,408
+318
+1% +$5.42K ﹤0.01% 1548
2023
Q1
$527K Sell
28,090
-1,870
-6% -$30.7K ﹤0.01% 1401
2022
Q4
$413K Buy
29,960
+116
+0.4% +$1.78K ﹤0.01% 1553
2022
Q3
$571K Buy
29,844
+300
+1% +$5.47K 0.01% 1366
2022
Q2
$451K Sell
29,544
-341
-1% -$5.04K ﹤0.01% 1510
2022
Q1
$609K Sell
29,885
-1,054
-3% -$21.5K ﹤0.01% 1462
2021
Q4
$903K Buy
30,939
+20,326
+192% +$582K 0.01% 1293
2021
Q3
$229K Sell
10,613
-622
-6% -$15K ﹤0.01% 1950
2021
Q2
$288K Buy
+11,235
New +$240K ﹤0.01% 1907
2020
Q2
Sell
-10,129
Closed -$52K 1672
2020
Q1
$52K Sell
10,129
-444
-4% -$2.69K ﹤0.01% 1563
2019
Q4
$81K Buy
10,573
+489
+5% +$2.85K ﹤0.01% 1754
2019
Q3
$53K Sell
10,084
-78
-0.8% -$484 ﹤0.01% 1705
2019
Q2
$57K Buy
+10,162
New +$41.9K ﹤0.01% 1737
2016
Q2
Sell
-3,099
Closed -$9K 1404
2016
Q1
$9K Buy
3,099
+336
+12% +$1.8K ﹤0.01% 1291
2015
Q4
$23K Sell
2,763
-55
-2% -$444 ﹤0.01% 1189
2015
Q3
$20K Buy
2,818
+35
+1% +$292 ﹤0.01% 1294
2015
Q2
$26K Buy
2,783
+233
+9% +$2.24K ﹤0.01% 1355
2015
Q1
$24K Buy
2,550
+237
+10% +$2.28K ﹤0.01% 928
2014
Q4
$23K Sell
2,313
-5
-0.2% -$50 ﹤0.01% 851
2014
Q3
$22K Buy
2,318
+9
+0.4% +$101 ﹤0.01% 838
2014
Q2
$30K Sell
2,309
-264
-10% -$3.33K ﹤0.01% 866
2014
Q1
$34K Buy
2,573
+194
+8% +$2.55K 0.01% 827
2013
Q4
$23K Buy
+2,379
New +$22.4K ﹤0.01% 835

Other funds holding CDMO

Amalgamated Bank's CDMO Position: Q1 2025 in Review

Amalgamated Bank sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 2,091 shares — an estimated $26K sold.

Amalgamated Bank first reported a position in CDMO in Q4 2013 and held it in 29 quarters. The position peaked at $903K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Amalgamated Bank reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Amalgamated Bank sold 2,091 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $26K.
  • Amalgamated Bank first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2013 and held it in 29 quarters.
  • Amalgamated Bank's Avid Bioservices, Inc. Common Stock position peaked at $903K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Amalgamated Bank's 13F filing for Q1 2025, filed 25 Apr 2025.